BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 22267278)

  • 1. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
    Di Dalmazi G; Vicennati V; Rinaldi E; Morselli-Labate AM; Giampalma E; Mosconi C; Pagotto U; Pasquali R
    Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
    Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed diagnostic criteria for subclinical Cushing's syndrome associated with adrenal incidentaloma.
    Akehi Y; Kawate H; Murase K; Nagaishi R; Nomiyama T; Nomura M; Takayanagi R; Yanase T
    Endocr J; 2013; 60(7):903-12. PubMed ID: 23574729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical Cushing's syndrome: current concepts and trends.
    Zografos GN; Perysinakis I; Vassilatou E
    Hormones (Athens); 2014; 13(3):323-37. PubMed ID: 25079456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult Cushing's syndrome in type-2 diabetes.
    Catargi B; Rigalleau V; Poussin A; Ronci-Chaix N; Bex V; Vergnot V; Gin H; Roger P; Tabarin A
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5808-13. PubMed ID: 14671173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of adrenal subclinical hypercortisolism on hypertension in patients with adrenal incidentaloma.
    Oki K; Yamane K; Nakanishi S; Shiwa T; Kohno N
    Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):244-7. PubMed ID: 22328110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
    Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
    J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
    Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
    Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
    Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
    J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity.
    Araujo-Castro M; Pascual-Corrales E; Lamas C
    Ann Endocrinol (Paris); 2023 Apr; 84(2):272-284. PubMed ID: 36736771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and associated factors of subclinical hypercortisolism in patients with resistant hypertension.
    Martins LC; Conceição FL; Muxfeldt ES; Salles GF
    J Hypertens; 2012 May; 30(5):967-73. PubMed ID: 22406465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications.
    Vassilatou E; Vryonidou A; Ioannidis D; Paschou SA; Panagou M; Tzavara I
    Eur J Endocrinol; 2014 Jul; 171(1):37-45. PubMed ID: 24743396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of subclinical Cushing's syndrome after surgical and conservative treatment.
    Akaza I; Yoshimoto T; Iwashima F; Nakayama C; Doi M; Izumiyama H; Hirata Y
    Hypertens Res; 2011 Oct; 34(10):1111-5. PubMed ID: 21775997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes.
    Emral R; Uysal AR; Asik M; Gullu S; Corapcioglu D; Tonyukuk V; Erdogan G
    Endocr J; 2003 Aug; 50(4):399-408. PubMed ID: 14599113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.
    Tauchmanovà L; Rossi R; Biondi B; Pulcrano M; Nuzzo V; Palmieri EA; Fazio S; Lombardi G
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4872-8. PubMed ID: 12414841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism.
    Palmieri S; Morelli V; Polledri E; Fustinoni S; Mercadante R; Olgiati L; Eller Vainicher C; Cairoli E; Zhukouskaya VV; Beck-Peccoz P; Chiodini I
    Eur J Endocrinol; 2013 Mar; 168(3):289-96. PubMed ID: 23211572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment.
    Mazzuco TL; Bourdeau I; Lacroix A
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):203-10. PubMed ID: 19390321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term study of subclinical Cushing's syndrome shows high prevalence of extra-adrenal malignancy in patients with functioning bilateral adrenal tumors.
    Kawate H; Kohno M; Matsuda Y; Akehi Y; Tanabe M; Horiuchi T; Ohnaka K; Nomura M; Yanase T; Takayanagi R
    Endocr J; 2014; 61(12):1205-12. PubMed ID: 25223468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.